Interv Akut Kardiol. 2008;7(1):21-23

Bleeding scale and bleeding complication of the antithrombotic therapy in cardiologic patients

Róbert Ševčík¹, Jan Vojáček^1,2, Josef Bis¹, Hana Ševčíková¹, Jaroslav Dušek¹, Josef Šťásek²

¹ I. interní klinika Fakultní nemocnice v Hradci Králové

² Kardiocentrum dospělých, oddělení invazivní kardiologie interní kliniky 2. LF UK a FN Motol, Praha

Antithrombotic drugs are the cornerstone of the cardiovascular medicine. Bleeding is certainly the hottest problem of the chronic antithrombotic therapy. Contemporary bleeding scales do not assess bleeding complications of anticoagulation and/or antiaggregation therapy, because they were primarily designed for trombolysis in pantients with myocardial infarction. The new bleeding score proposal was developed to focus on chronic antithrombotic therapy and their complications. The recent data from many registers shows incorrect dosage of antithrombotic therapy and define risc factors of bleeding.

Keywords: antithrombotic therapy, bleeding scales, risc factors of bleeding

Published: March 27, 2008  Show citation